CD44 and neoplasm: Key differences involved enhanced communication in BR1 from the tumor cell cluster enriched in immune and cell-cycle-MPs (T2) to reactive microglia states (Mg9, Mg12–13), including upregulation of the microglia-activating MIF_CD74_CD44 axis73–75 (Figures 6B–C).